These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39047762)

  • 21. A Prospective Randomized Trial Comparing Hydrus and iStent Microinvasive Glaucoma Surgery Implants for Standalone Treatment of Open-Angle Glaucoma: The COMPARE Study.
    Ahmed IIK; Fea A; Au L; Ang RE; Harasymowycz P; Jampel HD; Samuelson TW; Chang DF; Rhee DJ;
    Ophthalmology; 2020 Jan; 127(1):52-61. PubMed ID: 31034856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-year outcomes of microshunt implantation in pseudoexfoliation glaucoma.
    Nobl M; Freissinger S; Kassumeh S; Priglinger S; Mackert MJ
    PLoS One; 2021; 16(8):e0256670. PubMed ID: 34449795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ab Externo SIBS Microshunt with Mitomycin C for Open-Angle Glaucoma: Three-Year Results as a Primary Surgical Intervention.
    Armstrong JJ; De Francesco T; Ma J; Schlenker MB; Ahmed IIK
    Ophthalmol Glaucoma; 2023; 6(5):480-492. PubMed ID: 37044278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathological findings of failed blebs after microinvasive bleb surgery with the XEN Gel Stent and Preserflo MicroShunt.
    Neubauer J; Suesskind D; Gassel CJ; Nasyrov E; Voykov B
    Graefes Arch Clin Exp Ophthalmol; 2024 Sep; 262(9):2977-2984. PubMed ID: 38625448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study.
    Beckers HJM; Aptel F; Webers CAB; Bluwol E; Martínez-de-la-Casa JM; García-Feijoó J; Lachkar Y; Méndez-Hernández CD; Riss I; Shao H; Pinchuk L; Angeles R; Sadruddin O; Shaarawy TM
    Ophthalmol Glaucoma; 2022; 5(2):195-209. PubMed ID: 34329772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomes.
    Triolo G; Wang J; Aguilar-Munoa S; Jayaram H; Barton K
    Eye (Lond); 2023 Aug; 37(12):2535-2541. PubMed ID: 36577805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One Year Results of the Preserflo MicroShunt Implantation for Refractory Glaucoma.
    Seuthe AM; Erokhina M; Szurman P; Haus A
    J Glaucoma; 2023 May; 32(5):414-419. PubMed ID: 36795529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
    Midha N; Gillmann K; Chaudhary A; Mermoud A; Mansouri K
    J Glaucoma; 2020 Jan; 29(1):11-14. PubMed ID: 31702711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and effectiveness of gold glaucoma micro shunt for reducing intraocular pressure in Japanese patients with open angle glaucoma.
    Tanito M; Chihara E
    Jpn J Ophthalmol; 2017 Sep; 61(5):388-394. PubMed ID: 28600745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of PreserFlo MicroShunt Implantation and Its Effects on Intraocular Inflammation through Laser Flare Photometry.
    Cagini C; Boni N; Bonifazi T; Fruttini D; Della Lena F
    J Ophthalmol; 2024; 2024():2447721. PubMed ID: 39081855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony.
    Lüke JN; Reinking N; Dietlein TS; Haendel A; Enders P; Lappas A
    Int Ophthalmol; 2023 Aug; 43(8):2643-2651. PubMed ID: 36905460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy.
    Micheletti E; Riva I; Bruttini C; Quaranta L
    J Glaucoma; 2020 Aug; 29(8):e87-e90. PubMed ID: 32568812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRESERFLO ™ MicroShunt versus trabeculectomy: 1-year results on efficacy and safety.
    Jamke M; Herber R; Haase MA; Jasper CS; Pillunat LE; Pillunat KR
    Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2901-2915. PubMed ID: 37133501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-Year Follow-up of a Novel Aqueous Humor MicroShunt.
    Batlle JF; Fantes F; Riss I; Pinchuk L; Alburquerque R; Kato YP; Arrieta E; Peralta AC; Palmberg P; Parrish RK; Weber BA; Parel JM
    J Glaucoma; 2016 Feb; 25(2):e58-65. PubMed ID: 26766400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two-Year Outcomes of XEN Gel Stent Surgery in Patients with Open-Angle Glaucoma.
    Mansouri K; Bravetti GE; Gillmann K; Rao HL; Ch'ng TW; Mermoud A
    Ophthalmol Glaucoma; 2019; 2(5):309-318. PubMed ID: 32672673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.
    Samuelson TW; Sarkisian SR; Lubeck DM; Stiles MC; Duh YJ; Romo EA; Giamporcaro JE; Hornbeak DM; Katz LJ;
    Ophthalmology; 2019 Jun; 126(6):811-821. PubMed ID: 30880108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors.
    Gillmann K; Bravetti GE; Rao HL; Mermoud A; Mansouri K
    Acta Ophthalmol; 2021 Jun; 99(4):e531-e539. PubMed ID: 32930515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter clinical trial of high-intensity focused ultrasound treatment in glaucoma patients without previous filtering surgery.
    Aptel F; Denis P; Rouland JF; Renard JP; Bron A
    Acta Ophthalmol; 2016 Aug; 94(5):e268-77. PubMed ID: 26547890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Retrospective Analysis of Safety and Efficacy of XEN 45 Microstent Combined Cataract Surgery in Open-Angle Glaucoma over 24 Months.
    Subaşı S; Yüksel N; Özer F; Yılmaz Tugan B; Pirhan D
    Turk J Ophthalmol; 2021 Jun; 51(3):139-145. PubMed ID: 34187146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bleb vessel density as a predictive factor for surgical revisions after Preserflo Microshunt implantation.
    Schneider S; Kallab M; Murauer O; Reisinger AS; Strohmaier S; Huang AS; Bolz M; Strohmaier CA
    Acta Ophthalmol; 2024 Aug; 102(5):e797-e804. PubMed ID: 38306110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.